Free Trial

Veradigm (NASDAQ:MDRX) Shares Gap Down - Time to Sell?

Veradigm logo with Business Services background
Image from MarketBeat Media, LLC.

Key Points

  • Shares gapped down before the open—Veradigm closed at $4.96, opened at $4.4750 and was last trading around $4.90 on a light volume of 4,218 shares.
  • Wall Street Zen upgraded the stock to a "hold" in a March 7 research note, signaling modest analyst confidence rather than a buy endorsement.
  • Key metrics: market cap about $571.9M, P/E 23.25, beta 0.52, with the 50-day moving average at $4.50 and the 200-day at $4.65.
  • Interested in Veradigm? Here are five stocks we like better.

Veradigm Inc. (NASDAQ:MDRX - Get Free Report) gapped down before the market opened on Thursday . The stock had previously closed at $4.96, but opened at $4.4750. Veradigm shares last traded at $4.90, with a volume of 4,218 shares.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen raised shares of Veradigm to a "hold" rating in a research note on Saturday, March 7th.

View Our Latest Stock Analysis on MDRX

Veradigm Price Performance

The company's 50-day moving average is $4.50 and its 200-day moving average is $4.65. The firm has a market capitalization of $571.90 million, a price-to-earnings ratio of 23.25 and a beta of 0.52.

About Veradigm

(Get Free Report)

Veradigm, Inc NASDAQ: MDRX is a healthcare technology company that provides a comprehensive suite of clinical, financial and analytical solutions to medical practices, health systems and life sciences organizations. The company's offerings are designed to streamline electronic health record (EHR) workflows, optimize revenue cycle management and improve patient engagement through integrated software modules and cloud-based platforms.

Veradigm's product portfolio includes EHR and practice management systems tailored to ambulatory and specialty care settings, as well as revenue cycle management services that encompass billing, coding and claims processing.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Veradigm Right Now?

Before you consider Veradigm, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.

While Veradigm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines